| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.4M | +3653.3% |
| SG&A Expense | $12.0M | +132.8% |
| Operating Income | -$15.4M | -193.0% |
| Interest Expense | $40K | — |
| Pre-tax Income | -$17.8M | -3221.3% |
| Net Income | -$17.8M | -3227.5% |
| EPS (Basic) | -$20.53 | — |
| EPS (Diluted) | -$20.53 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $554K | -86.9% |
| Short-term Investments | $4.2M | +0.0% |
| Current Assets | $2.7M | -52.6% |
| Total Assets | $4.2M | -42.0% |
| Current Liabilities | $10.7M | +496.4% |
| Total Liabilities | $11.0M | +43.0% |
| Stockholders' Equity | -$6.8M | -1386.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.7M | -25.3% |
| Capital Expenditures | $51K | — |
| Investing Cash Flow | -$43K | -105.9% |
| Financing Cash Flow | $6.1M | -44.5% |
| Free Cash Flow | -$9.7M | — |